Repurposing a Histone Deacetylase 2 (HDAC-2) Specific Inhibitor as a Potential Treatment for Alzheimer's Disease (AD)

被引：0
|
作者：
Ibia, I. E. [1 ]
Mobbs, C. V. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Reston, VA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
B127
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [1] Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
    Damaskos, Christos
    Psilopatis, Iason
    Garmpi, Anna
    Dimitroulis, Dimitrios
    Nikolettos, Konstantinos
    Vrettou, Kleio
    Sarantis, Panagiotis
    Koustas, Evangelos
    Kouraklis, Gregory
    Antoniou, Efstathios A.
    Karamouzis, Michail V.
    Nikolettos, Nikolaos
    Tsikouras, Panagiotis
    Marinos, Georgios
    Kontomanolis, Emmanouil
    Kontzoglou, Konstantinos
    Garmpis, Nikolaos
    CANCERS, 2024, 16 (01)
  • [2] Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
    Garmpis, Nikolaos
    Damaskos, Christos
    Dimitroulis, Dimitrios
    Kouraklis, Gregory
    Garmpi, Anna
    Sarantis, Panagiotis
    Koustas, Evangelos
    Patsouras, Alexandros
    Psilopatis, Iason
    Antoniou, Efstathios A.
    Karamouzis, Michail, V
    Kontzoglou, Konstantinos
    Nonni, Afroditi
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (10):
  • [3] Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
    Urias, Beatriz Silva
    Pavan, Aline Renata
    Albuquerque, Gabriela Ribeiro
    Prokopczyk, Igor Muccilo
    Ferreira Alves, Tania Mara
    Ferreira de Melo, Thais Regina
    Rodrigues Sartori, Geraldo
    Martins da Silva, Joao Herminio
    Chin, Chung Man
    Dos Santos, Jean Leandro
    PHARMACEUTICALS, 2022, 15 (10)
  • [4] Histone deacetylases in replicative senescence:: evidence for a senescence-specific form of HDAC-2
    Wagner, M
    Brosch, G
    Zwerschke, W
    Seto, E
    Loidl, P
    Jansen-Dürr, P
    FEBS LETTERS, 2001, 499 (1-2) : 101 - 106
  • [5] Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
    Giaginis, Constantinos
    Alexandrou, Paraskevi
    Delladetsima, Ioanna
    Giannopoulou, Ioanna
    Patsouris, Efstratios
    Theocharis, Stamatios
    TUMOR BIOLOGY, 2014, 35 (01) : 61 - 71
  • [6] Potential role of histone deacetylase 3 specific inhibitor Compound A in diabetes treatment
    LEI Lei
    XIA Jie
    LIU Quan
    SUN Su-juan
    LIU Shuai-nan
    LI Cai-na
    CAO Hui
    HUAN Yi
    SHEN Zhu-fang
    中国药理学与毒理学杂志, 2019, (10) : 758 - 758
  • [7] A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease
    Choong, Chi-Jing
    Sasaki, Tsutomu
    Hayakawa, Hideki
    Yasuda, Toru
    Baba, Kousuke
    Hirata, Yoshiyuki
    Uesato, Shinichi
    Mochizuki, Hideki
    NEUROBIOLOGY OF AGING, 2016, 37 : 103 - 116
  • [8] Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
    Wataru Araki
    BMC Medicine, 11
  • [9] Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
    Araki, Wataru
    BMC MEDICINE, 2013, 11
  • [10] The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
    Krämer, OH
    Zhu, P
    Ostendorff, HP
    Golebiewski, M
    Tiefenbach, J
    Peters, MA
    Brill, B
    Groner, B
    Bach, I
    Heinzel, T
    Göttlicher, M
    EMBO JOURNAL, 2003, 22 (13): : 3411 - 3420
12345